AGP Picks
View all

Healthcare Wire Texas: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Wire Texas.

Press releases published on October 14, 2026

Working Solutions Marks 30 Years with Brand Refresh and New Digital Experience
Tylock Nasser Vision Helps Lead First-of-Its-Kind Humanitarian Refractive Surgery Mission in Cusco, Peru
Black Horse Health Names Ruth Ann Rigby Chief Strategy Officer
VMD Sciences Unveils VMD Access International at WSAVA 2026
EmblemHealth Maintains 4-Star Medicare Rating, Highlighting Sustained Quality Performance
Golden Touch Fusion CBD Gummies: Official Product Information for Adults as the Federal Hemp Definition Changes November 12, 2026
Allsup Supports Cancer And Careers’ Free 12th Annual West Coast Conference On Work & Cancer
When Vision Changes: 5 Ways to Navigate What Comes Next
National Stem Cell Foundation Joins with Axiom Space and the Saudi Space Agency to Expand Study of Neurodegenerative Disease in Microgravity
BayCare Proton Center Opens
A Pie in the Face for a Purpose: Legend Senior Living’s CEO, COO, and CFO Get Pied to Support the Alzheimer’s Association
Cloud-Clone Primary Feline Cells: Categorised Portfolio for Full-Spectrum Veterinary Research
Siren Biotechnology Appoints Former FDA CBER Oncology Branch Chief to Clinical and Scientific Advisory Board
SSDI Beneficiaries To Receive 3.6% COLA Increase In 2027, Allsup Reports
Nova Leap Health Corp. to Highlight Record Performance at Planet MicroCap Showcase Toronto
Valneva to Present and Hold Investor Meetings at Upcoming U.S. and European Healthcare Conferences
Valneva présentera ses activités et rencontrera les investisseurs lors de prochaines conférences santé  aux États-Unis et en Europe
Medicaid work requirements start Jan. 1, but many enrollees should prepare now
Overcoming Post-Separation Abuse: Family Law Attorney Shares Protective Measures for Co-Parents During Domestic Violence Awareness Month
Elevar Therapeutics Resubmits New Drug Application to FDA for Combination of Camrelizumab plus Rivoceranib for Use as a First-line Treatment Option for Unresectable or Metastatic Hepatocellular Carcinoma

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Healthcare Wire Texas

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.